10/26/07 update
The Nasdaq Biotech Index had a decent week, closing Friday up 11.58% YTD (vs. up 8.87% YTD a week ago). But the larger-cap biotech rally did little for the Charity Contest portfolios' median, which finished the week down -7.50% YTD (vs. down -7.96% a week ago).
At week's end 10 of the 31 Contest portfolios were in the black YTD, with just the top two contestants beating the NBI. TECHNET's portfolio (up 26.8% YTD) is still in the lead and I'm in second place (up 13.4% YTD).
Have a wonderful weekend everyone!
Below is the Top Ten list on 10/26/07:
10/26/07
Rank Name Total
1 TECHNET 26,807
2 BULBA 13,427
3 MOPGCW 10,648
4 FILOF 6,462
5 ROBERT 6,296
6 WILDER 5,078
7 FRED 4,742
8 MANNY 3,261
9 PGONEIL 2,569
10 QUID 1,522
BIVN was bought for $5.60 by Genzyme and I set that as the stock price.
(All corrections, especially adjustments for splits, greatly appreciated.) |
